BioSpace News Archive

Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced it has entered into an agreement with Bioline Supply to distribute the CompuFlo® Epidural System and related disposables in Spain.

Blue Earth Diagnostics Announces Publication of Post-hoc Analysis Evaluating Impact of Urinary Activity on Image Interpretation of POSLUMA ® (Flotufolastat F 18) PET in Prostate Cancer.

bioAffinity Technologies, Inc. announced that David Elzi, Ph.D., bioAffinity Technologies Vice President of Research, has been named to the Membership Committee of the American Society for Cell Biology.

Ambrx Biopharma today announced a clinical update regarding its proprietary anti-PSMA antibody drug conjugate (ADC) ARX517 in the ongoing APEX-01 Phase 1 / 2 dose escalation and dose expansion clinical trial in metastatic castration-resistant prostate cancer (mCRPC).

Kineta, Inc. announced today that it will host a virtual KOL event to discuss new data from the VISTA-101 clinical trial of KVA12123 in patients with advanced solid tumors.

Evommune, Inc. and Accutar Biotechnology Inc. today announced a new strategic partnership focused on the discovery of novel small molecule drug candidates in chronic inflammatory diseases.

Apyx Medical Corporation today announced the appointment of Matthew Hill to the position of Chief Financial Officer, effective December 4, 2023.

InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”) will present at the Sidoti Small-Cap Virtual Investor Conference at 8:30 a.m. ET on Wednesday, December 6, 2023.

Cyclacel Pharmaceuticals, Inc. announced that it received a notice of non-compliance from Nasdaq Stock Market LLC on November 21, 2023 stating that, as a result of not having timely filed its quarterly report on Form 10-Q for the quarter ended September 30, 2023, the Company is not in compliance with Nasdaq Listing Rule 5250, which requires timely filing of periodic financial reports with the U.S. Securities and Exchange Commission.

Alpha Cognition Inc. reported financial results for the third quarter and nine months ended September 30, 2023, and provided a corporate update.